Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bright Minds Biosciences Inc. (DRUG)
:DRUG
DRUG Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.93 - $79.02
Previous Close$40.4
Volume34.65K
Average Volume (3M)82.95K
Market Cap
$252.49M
Enterprise Value$239.48K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta6.28
Next Earnings
Mar 11, 2025EPS Estimate
-0.17Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.18
Shares Outstanding7,043,989
10 Day Avg. Volume64,048
30 Day Avg. Volume82,953
Standard Deviation5.76
R-Squared0.00296
Alpha0.88
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$84.33Price Target Upside133.29% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
---
Bright Minds Biosciences News
---
Bulls Say, Bears Say
Bulls Say
Analyst RecommendationAnalyst's recommendation initiates coverage of Bright Minds Biosciences with an Outperform rating.
Competitive AdvantageThe competitive positioning of BMB-101 includes the potential for once- or twice-daily dosing, which could provide an advantage over competitors that require more frequent dosing.
Financial StabilityBright Minds Biosciences has an adequate cash position to support operations for the next 12 months, indicating financial stability.
Bears Say
---
Options Prices
Currently, No data available
---
Ownership Overview
30.81% Insiders
4.68% Other Institutional Investors
64.35% Public Companies and
Individual Investors
DRUG FAQ
What was Bright Minds Biosciences Inc.’s price range in the past 12 months?
Bright Minds Biosciences Inc. lowest stock price was $0.93 and its highest was $79.02 in the past 12 months.
What is Bright Minds Biosciences Inc.’s market cap?
Bright Minds Biosciences Inc.’s market cap is $252.49M.
When is Bright Minds Biosciences Inc.’s upcoming earnings report date?
Bright Minds Biosciences Inc.’s upcoming earnings report date is Mar 11, 2025 which is in 17 days.
How were Bright Minds Biosciences Inc.’s earnings last quarter?
Bright Minds Biosciences Inc. released its earnings results on Aug 14, 2024. The company reported $0.037 earnings per share for the quarter, beating the consensus estimate of N/A by $0.037.
Is Bright Minds Biosciences Inc. overvalued?
According to Wall Street analysts Bright Minds Biosciences Inc.’s price is currently Undervalued.
Does Bright Minds Biosciences Inc. pay dividends?
Bright Minds Biosciences Inc. does not currently pay dividends.
What is Bright Minds Biosciences Inc.’s EPS estimate?
Bright Minds Biosciences Inc.’s EPS estimate is -0.17.
How many shares outstanding does Bright Minds Biosciences Inc. have?
Bright Minds Biosciences Inc. has 7,043,989 shares outstanding.
What happened to Bright Minds Biosciences Inc.’s price movement after its last earnings report?
Bright Minds Biosciences Inc. reported an EPS of $0.037 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.98%.
Which hedge fund is a major shareholder of Bright Minds Biosciences Inc.?
Currently, no hedge funds are holding shares in DRUG
---
Bright Minds Biosciences Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$84.33 (133.29% Upside)
$84.33 (133.29% Upside)
Blogger Sentiment
Bullish
DRUG Sentiment 70%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth C$1.4M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
1954.61%
12-Months-Change
Fundamentals
Return on Equity
-3.35%
Trailing 12-Months
Asset Growth
747.95%
Trailing 12-Months
Company Description
Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is a pre-clinical biosciences company. It is is focused on developing targeted therapies with the potential to improve the treatment of mental health and neurological disorders.
---
DRUG Stock 12 Month Forecast
Average Price Target
$84.33
▲(133.29% Upside)
Technical Analysis
Best Analysts Covering DRUG
1 Year
1 Year Success Rate
1/2 ratings generated profit
1 Year Average Return
-2.30%
reiterated a buy rating 9 days ago
Copying Yasmeen Rahimi's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -2.30% per trade.
---